The Potential of Hydrogen Sulfide Donors in Treating Cardiovascular Diseases.

Hydrogen sulfide (HS) has long been considered as a toxic gas, but as research progressed, the idea has been updated and it has now been shown to have potent protective effects at reasonable concentrations. HS is an endogenous gas signaling molecule in mammals and is produced by specific enzymes in different cell types. An increasing number of studies indicate that HS plays an important role in cardiovascular homeostasis, and in most cases, HS has been reported to be downregulated in cardiovascular diseases (CVDs). Similarly, in preclinical studies, HS has been shown to prevent CVDs and improve heart function after heart failure. Recently, many HS donors have been synthesized and tested in cellular and animal models. Moreover, numerous molecular mechanisms have been proposed to demonstrate the effects of these donors. In this review, we will provide an update on the role of HS in cardiovascular activities and its involvement in pathological states, with a special focus on the roles of exogenous HS in cardiac protection.